| Current Price | $30.33 | Mkt Cap | $4.3B |
|---|---|---|---|
| Open | $30.42 | P/E Ratio | 0.00 |
| Prev. Close | $30.33 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $30.18 - $31.03 | Volume | 721,557 |
| 52-Wk Range | $29.01 - $64.37 | Avg. Daily Vol. | 1,002,203 |
The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
| Current Price | $30.33 | Mkt Cap | $4.3B |
|---|---|---|---|
| Open | $30.42 | P/E Ratio | 0.00 |
| Prev. Close | $30.33 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $30.18 - $31.03 | Volume | 721,557 |
| 52-Wk Range | $29.01 - $64.37 | Avg. Daily Vol. | 1,002,203 |
The best Bull and Bear pitches based on recency and number of recommendations.
They have a new anticoagulant which in 300 humans, given preoperatively for knee replacement, yielded NO clots (as opposed to 15% for Lovenox) and a bleeding risk of 5%, compared to 8% for Lovenox. This is a game-changer.
Read the most recent pitches from players about IONS.
Recs
TMFAdriaCimino
(20.27)
Submitted: 7/3/2021 6:07:34 PM :
Start Price:
$40.22
NASDAQ:IONS Score:
-29.18
Ionis has several candidates in the pipeline and expects to have at least 12 commercialized products by 2026. If that happens, we can expect a big increase in revenue over the coming years.
Recs
MKWas
(< 20)
Submitted: 2/18/2021 3:01:53 PM :
Start Price:
$57.84
NASDAQ:IONS Score:
-63.56
A leaders in antisense oligonucleotides, an emerging technology used to control messenger RNA .
Recs
IndyAnthony
(82.68)
Submitted: 2/5/2021 11:57:00 PM :
Start Price:
$60.59
NASDAQ:IONS Score:
+66.49
This biotech pharma company has out performed the S&P 500 over the last 10 years by hundreds of percent, but over the last 5 years, IONS has lost to the market by almost 30%, with most of those losses coming in 2020. The Founders are still involved, but institutions own almost 87% of the company. Despite collaborations with Roche, Biogen, and AstraZeneca, I think this company will underperform the market over the next 5-10 years.
Find the members with the highest scoring picks in IONS.
yosemitebean (36.44) Score: +594.49
The Score Leader is the player with the highest score across all their picks in IONS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| uclajphil6 | 34.46 | 1/7/2009 |
|
3W | $13.98 | +116.95% | +408.52% | +291.57 | 0 Comment | |
| JerryDreamer | < 20 | 8/17/2009 |
|
3W | $15.37 | +97.33% | +361.17% | +263.84 | 1 Comment | |
| Supernanny543 | 42.14 | 8/5/2008 |
|
3W | $17.31 | +75.22% | +269.01% | +193.80 | 0 Comment | |
| CRAMERSUKS | 67.19 | 9/2/2008 |
|
5Y | $17.94 | +69.06% | +259.77% | +190.71 | 1 Comment | |
| schwah5 | 81.25 | 7/30/2008 |
|
NS | $16.61 | +82.60% | +268.51% | +185.91 | 0 Comment | |
| Geo113 | < 20 | 4/14/2008 |
|
3Y | $16.13 | +88.03% | +254.88% | +166.85 | 1 Comment | |
| showmethemoney08 | < 20 | 2/5/2008 |
|
3M | $15.88 | +90.99% | +247.82% | +156.83 | 0 Comment | |
| leafjumper | 83.88 | 3/20/2008 |
|
5Y | $14.34 | +111.51% | +261.79% | +150.28 | 1 Comment | |
| OriginalBarnacle | 48.89 |
|
|
1Y | $22.50 | +34.80% | +180.94% | +146.14 | 0 Comment | |
| DorkRockerGrrl | 70.79 | 3/20/2008 |
|
3M | $14.20 | +113.59% | +258.34% | +144.75 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
